doi: 10.1016/j.rbce.2017.06.003 33 CroeseJ.MillerG
Improving cardiometabolic health is not just supportive but may, in fact, be disease modifying if, in fact, it can slow clonal evolution toward myelofibrosis or AML
With more patients becoming aware of these potential risks, its likely that the MDL will continue to expand
Increases Libido : Notably improves sexual desire and performance, particularly in men with erectile dysfunction
Theyre experimental substances that have shown promise in animal studies but have never undergone proper human trials
Despite no difference in the improvement of fibrosis, Newsomes trial observed that a smaller proportion of patients in the semaglutide group (5%) experienced worsening of fibrosis compared to the placebo group (19%), suggesting a potential benefit[20]